SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-022282
Filing Date
2023-05-15
Accepted
2023-05-15 17:09:28
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eras-20230331.htm   iXBRL 10-Q 2276309
2 EX-31.1 eras-ex31_1.htm EX-31.1 18739
3 EX-31.2 eras-ex31_2.htm EX-31.2 18751
4 EX-32.1 eras-ex32_1.htm EX-32.1 10146
5 EX-32.2 eras-ex32_2.htm EX-32.2 10460
6 GRAPHIC img198687118_0.jpg GRAPHIC 1134186
  Complete submission text file 0000950170-23-022282.txt   12643313

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eras-20230331.xsd EX-101.SCH 57902
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eras-20230331_cal.xml EX-101.CAL 43968
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eras-20230331_pre.xml EX-101.PRE 359378
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eras-20230331_lab.xml EX-101.LAB 487517
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eras-20230331_def.xml EX-101.DEF 239538
67 EXTRACTED XBRL INSTANCE DOCUMENT eras-20230331_htm.xml XML 2259513
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40602 | Film No.: 23924159
SIC: 2834 Pharmaceutical Preparations